Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +0.93% | -2.70% | -16.28% |
May. 20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
May. 14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 93.71M | Sales 2025 * | 132M | Capitalization | 156M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -8M | EV / Sales 2024 * | 1.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
-4.7
x | P/E ratio 2025 * |
-16
x | Employees | 132 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.66% |
Latest transcript on OptiNose, Inc.
1 day | +0.93% | ||
1 week | -2.70% | ||
1 month | +18.92% | ||
3 months | -43.46% | ||
6 months | -14.29% | ||
Current year | -16.28% |
Managers | Title | Age | Since |
---|---|---|---|
Ramy Mahmoud
CEO | Chief Executive Officer | 59 | 09-12-31 |
Chief Tech/Sci/R&D Officer | - | 17-05-31 | |
John C. Messina
CTO | Chief Tech/Sci/R&D Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 17-09-30 | |
Sandra Helton
BRD | Director/Board Member | 74 | 18-02-21 |
Eric Bednarski
BRD | Director/Board Member | 52 | 21-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.08 | +0.93% | 490,878 |
24-05-30 | 1.07 | -.--% | 425,795 |
24-05-29 | 1.07 | -8.55% | 720,225 |
24-05-28 | 1.17 | +5.41% | 602,384 |
24-05-24 | 1.11 | -1.77% | 647,267 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.28% | 156M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- OPTN Stock